Raymond James & Associates’s Cognex CGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-55,500
Closed -$64K 4138
2021
Q4
$64K Buy
55,500
+15,700
+39% +$1.27M ﹤0.01% 3925
2021
Q3
$6K Buy
+39,800
New +$3.42M ﹤0.01% 4073
2021
Q2
Sell
-36,700
Closed -$22K 4104
2021
Q1
$22K Buy
+36,700
New +$3.06M ﹤0.01% 3914

Other funds holding CGNX

Raymond James & Associates's CGNX Position: Q3 2024 in Review

Raymond James & Associates increased its Cognex (CGNX) stake by 25% in Q3 2024, buying an estimated $4.05M and bringing the position to 474,163 shares worth $19.2M. The position accounts for 0.01% of the portfolio, ranked #843.

Raymond James & Associates first reported a position in CGNX in Q4 2014 and has held it in 40 quarters since. The position peaked at $26M in Q1 2022. 445 funds tracked by Wall St. Rank hold CGNX as of Q3 2024.

  • Raymond James & Associates held 474,163 shares of Cognex worth $19.2M as of Q3 2024.
  • Raymond James & Associates bought 95,063 Cognex shares in Q3 2024, an estimated $4.05M.
  • Cognex made up 0.01% of Raymond James & Associates's portfolio in Q3 2024, its #843 holding.
  • Raymond James & Associates first reported a position in Cognex in Q4 2014 and has held it in 40 quarters since.
  • Raymond James & Associates's Cognex position peaked at $26M in Q1 2022.
  • 445 funds tracked by Wall St. Rank held Cognex as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.